PVI
AXSM icon

Pura Vida Investments’s Axsome Therapeutics AXSM Stock Holding History

Pura Vida Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,000
Closed -$588K – 126
2020
Q1 		$588K Buy
+10,000
New +$815K 0.07% 84
2019
Q2 		– Sell
-157,400
Closed -$2.24M – 103
2019
Q1 		$2.24M Buy
157,400
+83,400
+113% +$774K 0.32% 75
2018
Q4 		$209K Buy
+74,000
New +$243K 0.04% 70

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pura Vida Investments's AXSM Position: Q4 2019 in Review

Pura Vida Investments sold out of Axsome Therapeutics (AXSM) in Q4 2019, closing a stake of 58,519 shares — an estimated $1.18M sold.

Pura Vida Investments first reported a position in AXSM in Q1 2019 and held it in 3 quarters. The position peaked at $3.04M in Q1 2019. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

  • Pura Vida Investments reported no remaining Axsome Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Pura Vida Investments sold 58,519 Axsome Therapeutics shares in Q4 2019, an estimated $1.18M.
  • Pura Vida Investments first reported a position in Axsome Therapeutics in Q1 2019 and held it in 3 quarters.
  • Pura Vida Investments's Axsome Therapeutics position peaked at $3.04M in Q1 2019.
  • 169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on Pura Vida Investments's 13F filing for Q4 2019, filed 14 Feb 2020.